Both Desheng and Insilico Biotechnology fell by 1.4-1.6% in this wave, while Zai Lab rose slightly. The innovative drug sector in Hong Kong stocks is under pressure recently, and the time for performance verification is here 🙈
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments